Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. ... a Memorial Sloan Kettering oncologist and researcher, is studying ranitidine and cancer risk.

Zantac and its generic varieties are coming off store shelves after the Food and Drug Administration revealed it found a chemical that could be linked to cancer. Monday, pharmacy chains CVS and ...

U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer ...

The lawsuits over the drug say its active ingredient, ranitidine, under some conditions turns into a cancer-causing substance called NDMA. Attorneys for Valadez had asked the jury to award $640 ...

Thousands of lawsuits make similar allegations that discontinued heartburn drug Zantac caused cancer. REUTERS. Attorneys for Valadez had asked the jury to award $640 million for her suffering.

CVS pulls Zantac after traces of known carcinogen 00:30. CVS Pharmacy announced it's pulling the heartburn medication Zantac from its shelves over a possible link to cancer.The popular over-the ...

The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above ...